Total Payments
$46,880
2024 Payments
$81.45
Companies
7
Transactions
82
Medicare Patients
5,307
Medicare Billing
$350,115
Payment Breakdown by Category
Other$36,925 (78.8%)
Travel$4,125 (8.8%)
Consulting$4,071 (8.7%)
Food & Beverage$1,720 (3.7%)
Education$40.33 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,925 | 19 | 78.8% |
| Travel and Lodging | $4,125 | 16 | 8.8% |
| Consulting Fee | $4,071 | 4 | 8.7% |
| Food and Beverage | $1,720 | 37 | 3.7% |
| Education | $40.33 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $40,147 | 65 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,946 | 12 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $1,500 | 1 | $0 (2017) |
| Becton, Dickinson and Company | $196.67 | 1 | $0 (2019) |
| Lilly USA, LLC | $46.08 | 1 | $0 (2024) |
| Abbott Laboratories | $24.74 | 1 | $0 (2022) |
| Novo Nordisk Inc | $20.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $81.45 | 3 | Lilly USA, LLC ($46.08) |
| 2022 | $44.21 | 2 | Abbott Laboratories ($24.74) |
| 2020 | $4,187 | 11 | AstraZeneca Pharmaceuticals LP ($3,887) |
| 2019 | $15,343 | 20 | Janssen Pharmaceuticals, Inc ($14,087) |
| 2018 | $17,951 | 23 | Janssen Pharmaceuticals, Inc ($17,951) |
| 2017 | $9,274 | 23 | Janssen Pharmaceuticals, Inc ($7,774) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $46.08 | General |
| Category: Diabetes | ||||||
| 09/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Obesity | ||||||
| 05/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Diabetes Care | ||||||
| 02/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/18/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/02/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/19/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | In-kind items and services | $726.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | In-kind items and services | $292.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $104.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | Cash or cash equivalent | $70.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $47.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $39.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $89.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $50.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/20/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $88.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2019 | Becton, Dickinson and Company | — | Consulting Fee | Cash or cash equivalent | $196.67 | General |
| 10/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $335.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,275.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,073 | 1,620 | $300,758 | $78,992 |
| 2022 | 25 | 1,128 | 1,703 | $299,148 | $76,485 |
| 2021 | 26 | 1,330 | 2,120 | $287,867 | $86,458 |
| 2020 | 28 | 1,776 | 2,716 | $381,069 | $108,180 |
Total Patients
5,307
Total Services
8,159
Medicare Billing
$350,115
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 322 | $141,366 | $26,165 | 18.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $36,844 | $15,385 | 41.8% |
| 77067 | Screening mammography | Office | 2023 | 47 | 47 | $20,991 | $5,762 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 103 | $32,136 | $5,686 | 17.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $7,952 | $4,507 | 56.7% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 26 | 26 | $5,070 | $3,340 | 65.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 174 | 402 | $8,442 | $3,299 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $8,680 | $1,976 | 22.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $5,504 | $1,959 | 35.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 37 | $11,802 | $1,843 | 15.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 36 | 36 | $6,588 | $1,805 | 27.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 55 | $1,705 | $1,645 | 96.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 51 | 51 | $1,310 | $1,232 | 94.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 26 | 26 | $1,170 | $1,037 | 88.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 23 | 24 | $1,080 | $917.24 | 84.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 79 | 101 | $3,055 | $748.34 | 24.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 15 | $3,405 | $624.15 | 18.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $527.00 | $508.47 | 96.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 31 | $1,922 | $307.53 | 16.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 120 | $600.00 | $97.52 | 16.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 11 | 11 | $277.75 | $69.74 | 25.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 13 | 17 | $208.25 | $48.82 | 23.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $122.50 | $29.12 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 319 | $131,780 | $25,118 | 19.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 128 | 128 | $38,486 | $16,499 | 42.9% |
About Dr. Bernard Quebral, MD
Dr. Bernard Quebral, MD is a Internal Medicine healthcare provider based in Woodbury, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235100892.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bernard Quebral, MD has received a total of $46,880 in payments from pharmaceutical and medical device companies, with $81.45 received in 2024. These payments were reported across 82 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($36,925).
As a Medicare-enrolled provider, Quebral has provided services to 5,307 Medicare beneficiaries, totaling 8,159 services with total Medicare billing of $350,115. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Woodbury, MN
- Active Since 01/31/2006
- Last Updated 11/15/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235100892
Products in Payments
- XARELTO (Drug) $40,123
- BYDUREON (Drug) $3,881
- RELISTOR (Drug) $1,500
- FARXIGA (Drug) $1,065
- MOUNJARO (Drug) $46.08
- FREESTYLE LIBRE 2 (Device) $24.74
- INVOKANA (Drug) $24.08
- Wegovy (Drug) $20.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Woodbury
Dr. Karen Schwartz, M.d, M.D
Internal Medicine — Payments: $393,480
Internal Medicine $393,480
Irina Murakhovskaya, M.d, M.D
Internal Medicine — Payments: $189,283
Internal Medicine $189,283
Anthony Bonett, Md, MD
Internal Medicine — Payments: $12,608
Internal Medicine $12,608
Dr. Linda Aquilino, D.o, D.O
Internal Medicine — Payments: $11,480
Internal Medicine $11,480
David Gehring, Md, MD
Internal Medicine — Payments: $3,934
Internal Medicine $3,934
Dr. Richard Shaw, D.o, D.O
Internal Medicine — Payments: $3,270
Internal Medicine $3,270